• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RETRACTABLE TECHNOLOGIES INC. VANISHPOINT SYRINGE; SYRINGE, ANTISTICK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RETRACTABLE TECHNOLOGIES INC. VANISHPOINT SYRINGE; SYRINGE, ANTISTICK Back to Search Results
Device Problem Material Puncture/Hole (1504)
Patient Problem Insufficient Information (4580)
Event Date 04/18/2021
Event Type  malfunction  
Event Description
Syringe use for covid-19 under emergency use authorization (eua): vanish point syringe was used to draw up the covid vaccine for administration at a clinic.The needle punctured the cap after recapping after it was drawn up.Proper recapping techniques were followed during this process.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VANISHPOINT SYRINGE
Type of Device
SYRINGE, ANTISTICK
Manufacturer (Section D)
RETRACTABLE TECHNOLOGIES INC.
MDR Report Key11796719
MDR Text Key249959887
Report NumberMW5101241
Device Sequence Number1
Product Code MEG
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-